Groenewald Ferdinand has filed 7 insider transactions across 2 companies since August 2024.
Most recent transaction: a grant/award of 60000 shares of Streamex Corp. ($STEX) on November 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Streamex Corp. | $STEX | Groenewald Ferdinand | CFO | A | Common Stock | 60000 | $0.00 | 295,000.0000 | 39,540,603 | 25.53% | 0.15% |
| Aug. 18, 2025 | Alaunos Therapeutics, Inc. | $TCRT | Groenewald Ferdinand | Vice President of Finance | A | Employee Stock Option (right to buy) | 4000 | $0.00 | 4,000.0000 | 1,601,252 | 9999.99% | 0.25% |
| Aug. 18, 2025 | Alaunos Therapeutics, Inc. | $TCRT | Groenewald Ferdinand | Vice President of Finance | A | Common Stock | 10775 | $0.00 | 10,775.0000 | 1,601,252 | 9999.99% | 0.67% |
| May 29, 2025 | Streamex Corp. | $STEX | Groenewald Ferdinand | Interim CFO | A | Common Stock | 175000 | $0.00 | 235,000.0000 | 24,252,482 | 291.67% | 0.72% |
| April 24, 2025 | Streamex Corp. | $STEX | Groenewald Ferdinand | Interim CFO | A | Common Stock | 35000 | $0.00 | 60,000.0000 | 24,252,482 | 140.00% | 0.14% |
| March 29, 2025 | Alaunos Therapeutics, Inc. | $TCRT | Groenewald Ferdinand | VP, Finance | A | Employee Stock Option (right to buy) | 3000 | $0.00 | 3,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 14, 2024 | Alaunos Therapeutics, Inc. | $TCRT | Groenewald Ferdinand | VP, Finance | A | Employee Stock Option (right to buy) | 1500 | $0.00 | 1,500.0000 | 0 | 9999.99% | 0.00% |